Analgesic Efficacy of Two Adjuvants During Spinal Anaesthesia.

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

February 1, 2017

Primary Completion Date

June 30, 2017

Study Completion Date

June 30, 2017

Conditions
Pain, Postoperative
Interventions
DRUG

Saline Solution

Spinal injection of 10 mg hyperbaric bupivacaine 0.5% (2 ml) + 100γ morphine (1ml) + 2.5 γ sufentanil (0.5ml) + 1 ml physiological saline.

DRUG

Magnesium Sulfate

Spinal injection of 10 mg hyperbaric Bupivacaine 0.5% (2 ml) + 100γ Morphine (1ml) + 2.5 γ sufentanil (0.5ml) + 100 mg MgSO4 (1 ml).

DRUG

Midazolam 5 MG/ML Injection

Spinal injection of 10 mg hyperbaric Bupivacaine 0.5% (2 ml) + 100γ Morphine (1ml) + 2.5 γ Sufentanil (0.5ml) + 2mg Midazolam (0.4 + 0.6cc physiological saline (1 ml)).

Trial Locations (2)

5000

Centre de Maternité de Monastir, Monastir

5100

Chu Tahar Sfar, Mahdia

All Listed Sponsors
lead

Centre de Maternité de Monastir

OTHER

NCT03458078 - Analgesic Efficacy of Two Adjuvants During Spinal Anaesthesia. | Biotech Hunter | Biotech Hunter